Cameroon Mobile Phone SMS Trial (CAMPS)

This study has been completed.
Sponsor:
Collaborator:
CIHR Canadian HIV Trials Network
Information provided by (Responsible Party):
Lawrence Mbuagbaw, Yaounde Central Hospital
ClinicalTrials.gov Identifier:
NCT01247181
First received: November 22, 2010
Last updated: September 7, 2011
Last verified: September 2011
  Purpose

The investigators hypothesize that sending weekly motivational text messages to people infected with HIV will encourage them to take their medication, compared to usual care.


Condition Intervention
Adherence
HIV
Other: Mobile phone text message
Other: Usual care

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Improving Adherence to HAART Using Mobile Phone Text Messages

Resource links provided by NLM:


Further study details as provided by Yaounde Central Hospital:

Primary Outcome Measures:
  • Adherence [ Time Frame: Change from baseline at 6 months ] [ Designated as safety issue: No ]
    Measured using the Visual Analogue Scale, Self Report and Pharmacy Refill Data


Secondary Outcome Measures:
  • Weight [ Time Frame: Change from baseline at 6 months ] [ Designated as safety issue: No ]
  • Body Mass Index [ Time Frame: Change from baseline at 6 months ] [ Designated as safety issue: No ]
  • CDC classification [ Time Frame: Change from baseline at 6 months ] [ Designated as safety issue: No ]
  • WHO Classification [ Time Frame: Change from baseline at 6 months ] [ Designated as safety issue: No ]
  • Mortality [ Time Frame: 6 months ] [ Designated as safety issue: No ]
    All cause mortality

  • CD4 count [ Time Frame: Change from baseline at 6 months ] [ Designated as safety issue: No ]
  • Viral load [ Time Frame: Change from baseline at 6 months ] [ Designated as safety issue: No ]
  • Quality of life [ Time Frame: Change from baseline at 6 months ] [ Designated as safety issue: No ]
    Measured using the SF-12 quality of life form


Enrollment: 200
Study Start Date: November 2010
Study Completion Date: July 2011
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Mobile phone text message Other: Mobile phone text message
Weekly message with motivational content
Other Names:
  • SMS
  • Texto
  • Text message
Active Comparator: No Mobile phone text message
Usual care provided at clinic
Other: Usual care
Usual care provided at clinic
Other Name: Routine care

  Eligibility

Ages Eligible for Study:   21 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • On HAART for at least 1 month
  • 21 years or more
  • Owns a mobile phone
  • Can read text messages

Exclusion Criteria:

  • On HAART for less than 1 month
  • Aged less than 21 years
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01247181

Locations
Cameroon
Yaounde Central Hospital Accredited Treatment Centre
Yaounde, Centre, Cameroon
Sponsors and Collaborators
Yaounde Central Hospital
CIHR Canadian HIV Trials Network
Investigators
Principal Investigator: Lawrence Mbuagbaw, MD, MPH Centre for the Development of Best Practices in Health
Study Director: Pierre Ongolo-Zogo, MD, BSc Centre for the Development of Best Practices in Health
  More Information

No publications provided by Yaounde Central Hospital

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Lawrence Mbuagbaw, MD, MPH, Yaounde Central Hospital
ClinicalTrials.gov Identifier: NCT01247181     History of Changes
Other Study ID Numbers: CAMPS, PACTR201011000261458
Study First Received: November 22, 2010
Last Updated: September 7, 2011
Health Authority: Cameroon: National Ethics Committee

Keywords provided by Yaounde Central Hospital:
compliance
observance
mobile phone
SMS
text message
ARV
HAART
AIDS

ClinicalTrials.gov processed this record on April 17, 2014